홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

(+-)-Ethopropazine

HCID 3290
새 반응
인쇄
기본 정보개요이름 및 식별자물성화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
1094-08-2
표준 SMILES
CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21
InChIKey
CDOZDBSBBXSXLB-UHFFFAOYSA-N
분자식
C19H24N2S
평균 분자량
312.5 g/mol
단동위원소 질량
312.16601995

개요

Profenamine is a member of the class of phenothiazines that is phenothiazine in which the hydrogen attached to the nitrogen is substituted by a 2-(diethylamino)propyl group. An antimuscarinic, it is used as the hydrochloride for the symptomatic treatment of Parkinson's disease. It has a role as an adrenergic antagonist, a histamine antagonist, an antiparkinson drug, a muscarinic antagonist and an antidyskinesia agent. It is a member of phenothiazines and a tertiary amino compound.

이름 및 식별자

우선 이름
(+-)-Ethopropazine
IUPAC
N,N-diethyl-1-phenothiazin-10-ylpropan-2-amine
영어명
ETHOPROPAZINE
분자식
C19H24N2S
분자량
312.47226

이름 및 동의어

ethopropazineProfenamineEthopromazine522-00-9ProfenaminumProfenamina2-Diethylamino-1-propyl-N-dibenzoparathiazineN,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamineW-483RP-3356SC-25387WI4P02YN1
이름 더 보기
ParkinparkTomilsc2538rp3356RP 3356RodipalRocipel
(+-)-Ethopropazine10-[2-(Diethylamino)propyl]phenothiazine10-[2-(Diethylamino)-1-Propyl]phenothiazine10H-Phenothiazine-10-ethanamine, N,N-diethyl-alpha-methyl-10-[2-(Diethylamino)-2-methylethyl]phenothiazinePHENOTHIAZINE, 10-(2-(DIETHYLAMINO)PROPYL)-diethyl[1-(10H-phenothiazin-10-yl)propan-2-yl]amineN,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine

데이터베이스 식별자

CAS
1094-08-2、522-00-9
PubChem CID
3290
DTXSID
DTXSID2023018
ChEMBL
CHEMBL1206
ChEBI
CHEBI:313639
UNII
7WI4P02YN1
EC Number
208-320-4

물성

구조 계산 물성

XLogP
4.8
극성 표면적
31.8 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
3
회전 가능 결합 수
5
무거운 원자 수
22
형식 전하
0
복잡도
322

실험 및 물리화학적 성질

LogP · 2건

5.2

4.77

Solubility5.24e-03 g/L
Human DrugsPharmaceuticals
Melting Point · 2건

166-168

64.5 °C

Physical DescriptionSolid
Collision Cross Section174.37 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
53 · 53-55°
밀도
1.107 · 1.1070 (rough estimate)
굴절률
1.58 · 1.5800 (estimate)
저장 조건
-20 °C · -20°C

화학 및 산업

약리 정보

ATC Code · 2건

N - Nervous system

QN - Nervous system

Protein Binding93%
Pharmacodynamics · 1건

Profenamine, a phenothiazine and antidyskinetic, is used in the treatment of Parkinson's disease. By improving muscle control and reducing stiffness, this drug permits more normal movements of the body as the disease symptoms are reduced. It is also used to control severe reactions to certain medicines such as reserpine, phenothiazines, chlorprothixene, thiothixene, loxapine, and haloperidol. Unlike other NMDA antagonists, profenamine — because of its anticholinergic action — is largely devoid of neurotoxic side effects. Profenamine also has a slight antihistaminic and local anesthetic effect.

Mechanism of Action · 1건

Profenamine's anti-Parkinson action can be attributed to its anticholinergic properties. Profenamine partially blocks central (striatal) cholinergic receptors, thereby helping to balance cholinergic and dopaminergic activity in the basal ganglia; salivation may be decreased, and smooth muscle may be relaxed. Drug-induced extrapyramidal symptoms and those due to parkinsonism may be relieved, but tardive dyskinesia is not alleviated and may be aggravated by anticholinergic effects. Profenamine's local anesthetic effect is due to its antagonism of the NMDA glutamate receptor. Glutamate is recognized as an important transmitter in nociceptive pathways, and the N-methyl-D-aspartate (NMDA) subtype of the glutamate receptor, in particular, has been implicated in the mediation of neuropathic pain. Excessive release of glutamate at NMDA receptors on dorsal horn neurons of the spinal cord results in hyperactivation and hypersensitivity of these receptors (perceived as hyperalgesia), thought to be an integral feature of neuropathic pain.

Biological Half-Life1 to 2 hours
MeSH Pharmacological Classification · 3건

Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only.

관련 반응

1건
반응 기록 만들기
HRID 473792 반응식
HRID 473792생성물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성화학 및 산업관련 반응화합물 노트
Nikkaji
J2.060E

Drugs that bind to but do not activate ADRENERGIC RECEPTORS. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters EPINEPHRINE and NOREPINEPHRINE.

Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system.

Absorption, Distribution and ExcretionWell-absorbed from the gastrointestinal tract.
Cellular LocationsCytoplasm

용도 및 제조

Use ClassificationPharmaceuticals

응용 분야

용도antiparkinsonian, anticholinergic

상·하류 제품 정보

상류 원료

염산마그네슘요오드 메탄페노티아진
추가 설명 · 1건

정의ChEBI: A member of the class of phenothiazines that is phenothiazine in which the hydrogen attached to the nitrogen is substituted by a 2-(diethylamino)propyl group. An antimuscarinic, it is used as the hydrochloride for the symptomatic treatment of Parkinson's d sease.